Molnupiravir

CAT: 0013-GTR19188124-02Size: 1 ml x 10 mM (in DMSO)Dry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19188124-02Size:1 ml x 10 mM (in DMSO)

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the antiviral ribonucleoside EIDD-1931. It is a broad-spectrum antiviral research compound active against SARS-CoV-2, influenza, and other coronaviruses in both in vitro and in vivo experimental models.

CAS Number

2492423-29-5

Product Name Alternative

2349386-89-4, Molnupiravir, MK4482, MK-4482, MK 4482, InfluenzaVirus, Influenza virus, Influenza Virus, Lagevrio, EIDD 2801, EIDD2801, EIDD-2801, SARSCoV, SARS-CoV

Field of Research

Infectious Disease & Virology

Purity

99.81% (May vary between batches)

Solubility

10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.07 mM) ; DMSO:257.5 mg/mL (781.94 mM)

Smiles

CC (C) C (=O) OC[C@H]1O[C@H] ([C@H] (O) [C@@H]1O) n1cc\c (=N/O) [nH]c1=O

Molecular Formula

C13H19N3O7

Molecular Weight

329.31

Storage Conditions

-20°C

Notes

For research use only.

Chemical Information

Molnupiravir

Molnupiravir is a nucleoside analogue that is N4-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N4-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. It has a role as an anticoronaviral agent, an antiviral drug and a prodrug. It is a ketoxime, an isopropyl ester and a nucleoside analogue. It is functionally related to a N(4)-hydroxycytidine.

CAS Number	2492423-29-5
PubChem CID	145996610
IUPAC Name	[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
Molecular Formula	C13H19N3O7
Molecular Weight	329.31
XLogP	-0.8
Topological Polar Surface Area	141
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	6
Heavy Atom Count	23
Formal Charge	0
Complexity	534

SMILES

CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O

InChI

InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1

InChIKey

HTNPEHXGEKVIHG-QCNRFFRDSA-N

Chemical Structure

2D Structure

CAS: 2492423-29-5

CID: 145996610

Formula: C13H19N3O7

MW: 329.31

Interactive 3D Structure

Loading 3D structure...

View on PubChem Raw 3D data

Computed Properties

Property	Value
Molecular Weight	329.31
XLogP3	-0.8
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	6
Exact Mass	329.12229995
Monoisotopic Mass	329.12229995
Topological Polar Surface Area	141 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	534
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently-Bonded Unit Count	1
Compound Is Canonicalized	Yes

Alternative Products

Catalog	Name
B8578-200	Molnupiravir
TMIH-0354-01	Molnupiravir-d7
A22165-50	Molnupiravir 50mg
AR-M05021-01	Molnupiravir Enantiomer
CS-O-40449	Molnupiravir 13C15N2
A22165-500	Molnupiravir 500mg
HY-135853R-01	Molnupiravir (Standard)
A22165-100	Molnupiravir 100mg
A22165-25	Molnupiravir 25mg
A22165-5	Molnupiravir 5mg

Molnupiravir

Chemical Information

Alternative Products

Popular Products